They talked as if they'd never see each other again.
Darryl Jackson spoke through tears during that video call last month, saying he wished he and his wife could trade places, just before COVID-19 forced her onto a hospital ventilator.
It was a dreaded step for Amanda Jackson, who at 38 was pregnant with the couple's fourth child. As her condition worsened over the days that followed, her husband was stricken with fear.
"I was just waiting for that phone call saying that she had passed," he said.
But a risky treatment of last resort not often used on pregnant women during the pandemic not only helped return Amanda to good health, but kept her on track to deliver her baby in July. Last week, Amanda was back at Hennepin Healthcare in Minneapolis for a checkup that found no lingering problems with her pregnancy.
Doctors say her story shows that they're still learning how best to treat COVID-19 patients. It also is evidence that risks from the pandemic endure even as cases decline and vaccine protection spreads.
"She's a walking miracle," said Dr. Tracy Prosen, a maternal-fetal medicine specialist at Hennepin Healthcare, which runs HCMC hospital in Minneapolis. "We weren't sure if mom was going to make it. We weren't sure if baby was going to make it."
![Amanda Jackson was helped into an exam room by her husband Darryl and medical assistant Vennice Harrell Wednesday morning. ] ANTHONY SOUFFLE • anthony.souffle@startribune.com](https://arc.stimg.co/startribunemedia/BUTA7RACOU3VHEBQLXQ6GXINOA.jpg?&w=1080)
In cases like Jackson's, doctors use technology called extracorporeal membrane oxygenation as a lung bypass machine, redirecting blood outside the body so the lungs have time to heal. But pregnant patients need blood thinners to manage the threat of clotting associated with the technology, called ECMO for short. Those medications can become a risk if doctors need to perform an emergency C-section to rescue the baby.